Mantente al tanto de los últimos avances en el cuidado del cáncer y estrategias para tratar tumores sólidos y cánceres de sangre, con créditos CME/CE en episodios seleccionados.
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
E190 • 45 mins • Feb 20, 2025
Charts
- 189Decreased by 57
- 172Increased by 15
- 124Decreased by 11
- 166Decreased by 14
- 85Decreased by 4
Episodios recientes

Feb 20, 2025
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
E190 • 45 mins

Feb 10, 2025
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
E189 • 20 mins

Jan 9, 2025
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
E188 • 36 mins

Oct 22, 2024
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
E187 • 21 mins

Oct 16, 2024
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations
E186 • 28 mins

Idioma
Inglés
País
Estados Unidos
Feed Host
Sitio web
Feed
Solicitar una actualización
Las actualizaciones pueden tardar unos minutos.